Dimensional Changes of Peri-implant Tissue in Immediate Implants With Individualized Healing Abutments
NCT ID: NCT06455436
Last Updated: 2024-06-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
32 participants
INTERVENTIONAL
2024-05-08
2026-07-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Abutment Configuration on Peri-implant Soft and Hard Tissue in the Esthetic Zone - Randomized Clinical Trial
NCT06407271
Digital Assessment at Peri-implant Tissues After Immediate Implants With Customized Healing Abutments and Connective Tissue Grafts
NCT05060055
Comparative Clinical Study of Conventional vs Customized Healing Abutments in Dental Implantology
NCT07031232
Study of Hard and Soft Tissue Behavior Around Abutments on Implants.
NCT05924451
Adhesion of Connective Tissue Around Laser-treated Abutments for Dental Implants - Clinical Trial in Humans
NCT01954485
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Methods: After the extraction, an immediate Klockner Vega+ implant will be placed and the gap will be filled with a bone substitute (Cerabone, Botiss). The patient will then be randomized to the control group (standard healing abutment) or the test group (custom healing abutment using CAD/CAM technique). In the latter case, a peripheral seal is achieved, allowing for wound closure and stabilization of the clot with the same shape as the crown in its transmucosal part.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control group
Will receive standard healing abutments
Standard healing abutment
Participants will undergo a surgery to place an immediate klockner dental implant and will be receive a standard healing abutment
Individualized healing abutment group
Will receive individualized healing abutments
Individualized healing abutment
Participants will undergo a surgery to place an immediate klockner dental implant and will be receive an individualized healing abutment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Standard healing abutment
Participants will undergo a surgery to place an immediate klockner dental implant and will be receive a standard healing abutment
Individualized healing abutment
Participants will undergo a surgery to place an immediate klockner dental implant and will be receive an individualized healing abutment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Need for extraction of an irrational tooth to be treated in the molar/premolar position of the upper/lower arch.
* Presence of 2mm of keratinized gingiva.
* Bone dehiscence in the alveolar walls of 2 mm. 2 mm.
* Adequate amount of bone in the interradicular septum to stabilize the implant (minimum height 10 mm, minimum width 4 mm at the base of the septum).
* Plaque index (FMSPI, full mouth score plaque index) \< 10%.
* Non-smokers or smokers of less than 10 cigarettes per day.
* Absence of systemic diseases that contraindicate implant surgery.
Exclusion Criteria
* Presence of adjacent implants.
* \< 2mm of keratinized gingiva.
* Presence of active infection (fistula, suppuration) at the extraction site.
* Presence of apical granuloma \>2mm in diameter in the root(s) of the tooth or teeth to be extracted.
* Residual bone apical to the extraction insufficient to anchor the implant.
* Pregnant or lactating women.
* Severe cognitive or psychiatric disorders.
* Compromised general health status ( ASA IV).
* Use of drugs that alter bone metabolism and healing.
* Absence of manual primary stability of the implant
* Bone dehiscence or fenestration after implant placement (manual rotation).
* Gap 2mm between the implant and the vestibular bone wall.
25 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitat Internacional de Catalunya
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matteo Albertini, PhD
Role: PRINCIPAL_INVESTIGATOR
Universidad Internacional de Catalunya
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universitat Internacional de Catalunya
Barcelona, Catalonia, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
PER-ECL-2023-10
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.